Drug intelligence / Profile preview

polyethylene glycol 3350 + mannitol

Development stage
Unknown
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

Polyethylene glycol 3350 + mannitol is an oral osmotic laxative formulation developed by Bayer, currently evaluated in Phase 4 clinical trials for the treatment of occasional constipation. The formulation combines polyethylene glycol (PEG) 3350, a non-absorbable polymer that retains water in the intestinal lumen through osmotic pressure to soften stool, with mannitol, a sugar alcohol. In this specific product development context, mannitol is utilized primarily as a flavoring agent to enhance the palatability and taste acceptability of the PEG 3350 solution, rather than as a primary active therapeutic ingredient. The combination aims to improve patient compliance by addressing the taste profile of standard PEG 3350 treatments.

Other names
PEG 3350 + mannitolmacrogol 3350 + mannitol

Beyond the preview

Go deeper on polyethylene glycol 3350 + mannitol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 3350 + mannitol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call